BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17174104)

  • 1. Modeling non-random deletions in cancer.
    Kost-Alimova M; Imreh S
    Semin Cancer Biol; 2007 Feb; 17(1):19-30. PubMed ID: 17174104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionarily plastic regions at human 3p21.3 coincide with tumor breakpoints identified by the "elimination test".
    Darai E; Kost-Alimova M; Kiss H; Kansoul H; Klein G; Imreh S
    Genomics; 2005 Jul; 86(1):1-12. PubMed ID: 15913951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microcell hybrid-based "elimination test" identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer.
    Kholodnyuk ID; Kost-Alimova M; Yang Y; Kiss H; Fedorova L; Klein G; Imreh S
    Genes Chromosomes Cancer; 2002 Jul; 34(3):341-4. PubMed ID: 12007195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors.
    Yang Y; Kiss H; Kost-Alimova M; Kedra D; Fransson I; Seroussi E; Li J; Szeles A; Kholodnyuk I; Imreh MP; Fodor K; Hadlaczky G; Klein G; Dumanski JP; Imreh S
    Genomics; 1999 Dec; 62(2):147-55. PubMed ID: 10610706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.
    Kost-Alimova M; Kiss H; Fedorova L; Yang Y; Dumanski JP; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6622-7. PubMed ID: 12738884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.
    Angeloni D
    Brief Funct Genomic Proteomic; 2007 Mar; 6(1):19-39. PubMed ID: 17525073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3.
    Kiss H; Yang Y; Kiss C; Andersson K; Klein G; Imreh S; Dumanski JP
    Eur J Hum Genet; 2002 Jan; 10(1):52-61. PubMed ID: 11896456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM.
    Szeles A; Yang Y; Sandlund AM; Kholodnyuk I; Kiss H; Kost-Alimova M; Zabarovsky ER; Stanbridge E; Klein G; Imreh S
    Genes Chromosomes Cancer; 1997 Dec; 20(4):329-36. PubMed ID: 9408748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors.
    Hoebeeck J; Michels E; Menten B; Van Roy N; Eggert A; Schramm A; De Preter K; Yigit N; De Smet E; De Paepe A; Laureys G; Vandesompele J; Speleman F
    Int J Cancer; 2007 Feb; 120(3):533-8. PubMed ID: 17096344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of lung tumor suppressor activity at 3p21.3.
    ter Elst A; Hiemstra BE; van der Vlies P; Kamminga W; van der Veen AY; Davelaar I; Terpstra P; te Meerman GJ; Gerbens F; Kok K; Buys CH
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1077-93. PubMed ID: 16958100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From identification of genomic polymorphism to diagnostic and prognostic markers of human epithelial tumors].
    Braga EA; Kiselev LL; Zabarovskiĭ ER
    Mol Biol (Mosk); 2004; 38(2):179-90. PubMed ID: 15125222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.
    Kok K; Naylor SL; Buys CH
    Adv Cancer Res; 1997; 71():27-92. PubMed ID: 9111863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.
    McAvoy S; Zhu Y; Perez DS; James CD; Smith DI
    Genes Chromosomes Cancer; 2008 Feb; 47(2):165-74. PubMed ID: 18008369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice.
    Kholodnyuk ID; Kozireva S; Kost-Alimova M; Kashuba V; Klein G; Imreh S
    Int J Cancer; 2006 Jul; 119(1):99-107. PubMed ID: 16432833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.
    Yang Y; Kost-Alimova M; Ingvarsson S; Qianhui Q; Kiss H; Szeles A; Kholodnyuk I; Cuthbert A; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1136-41. PubMed ID: 11158607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular senescence bypass screen identifies new putative tumor suppressor genes.
    Leal JF; Fominaya J; Cascón A; Guijarro MV; Blanco-Aparicio C; Lleonart M; Castro ME; Ramon Y Cajal S; Robledo M; Beach DH; Carnero A
    Oncogene; 2008 Mar; 27(14):1961-70. PubMed ID: 17968325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.